Caplight Directory>Companies>BioTryp Therapeutics-preview>Biotryp


BioTryp Therapeutics

BioTryp Therapeutics

Private
CambridgeN/Ahttps://biotryp.com/

Last Round

Grant

Nov 24, 2025

Total Funding Raised

$940,000

Company Overview

BioTryp Therapeutics is a biotechnology company developing novel oral antibiofilm therapies for bacterial infections.

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BioTryp Therapeutics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

BioTryp Therapeutics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantNov 24, 2025
Pre SeedAug 15, 2024
View all Funding Rounds

Key People

Founding team and executive leadership

Ashraf Zarkan

CEO & Co-Founder

Founding Team

BioTryp Therapeutics Investors

Notable investors and investment history

InvestorRounds
Founders at the University of CambridgePre Seed
QUBIS Innovation FundPre Seed
National Research Council Canada Industrial Research Assistance ProgramGrant
Innovate UKGrant
Parkwalk AdvisorsPre Seed
University of Cambridge Venture FundPre Seed
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 24, 2025

    $540K raised from Innovate UK and NRC IRAP.

  • Aug 15, 2024

    $400K raised from Parkwalk Advisors and QUBIS.

View all signals

BioTryp Therapeutics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BioTryp Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BioTryp Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge
Employee Range4
Year Founded2024
Last FundingNov 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.